What drove the large increase in Parker-Hannifin's FY2004 earnings?

Net income rose to $345.8 million from $196.3 million, mainly from higher sales volume in the Industrial segment, better gross margins from manufacturing efficiency and cost initiatives, and lower interest expense. The effective tax rate also fell to 30.0% from 34.0%, due to a capital loss used to offset capital gains and an IRS audit settlement. Some of this benefit is non-recurring in nature, so investors should separate it from run-rate operating performance.

How strong is Parker-Hannifin's balance sheet and liquidity position?

The balance sheet strengthened considerably. Debt fell by about $400 million to $989 million, the debt-to-debt-equity ratio dropped to 24.9%, and the company holds $825 million in committed credit lines with A-1/P-1 commercial paper ratings. Working capital reached $1.28 billion with a current ratio of 2.01. Management reports compliance with all covenants, including the debt-to-total-capitalization limit of less than 50%.

What are the main risks and outlook items disclosed for fiscal 2005?

Management highlighted rising raw material costs that may not be fully recovered through pricing, continued pressure from employee retirement and health care costs, and expected 2005 pension expense about $13 million higher than 2004. Environmental remediation covers 28 facilities and two off-site and three regional sites, with a reserve of $20.4 million against a possible total liability of up to $60.4 million. Management expects sales and operating income to rise in FY2005 on stronger North American industrial demand and commercial aerospace recovery, though additional business realignment charges may be needed.

How much is Parker-Hannifin investing in acquisitions and R&D?

The company spent about $200 million net on acquisitions in FY2004, mainly the $255 million Denison International purchase (completed February 2004), with additional tuck-in deals. Research and development costs were $143.1 million, up from $122.7 million, though $48.4 million of that was reimbursed by customers. Management said it is exploring further acquisitions, which may be funded with borrowings, and capital expenditures are expected to be about 3.5% of sales in FY2005.

PH 10-K FY2004 Annual Report — Revenue, Net Income, EPS

01—Abstract

Summary

Summary of the 10-K filed September 3, 2004. Cited figures are marked; the original filing is the authoritative source.

Parker-Hannifin's fiscal 2004 10-K (year ended June 30, 2004) shows a sharp earnings recovery.

Net sales rose 10.9% to $7.107 billion^a, driven mainly by higher volume in the Industrial North American and International operations, plus the Denison acquisition and currency effects. Gross margin expanded to 19.2% from 17.2%, and net income nearly doubled to $345.8 million ($2.91 diluted EPS) from $196.3 million ($1.68), with net margin reaching 4.9%. Interest expense fell to $73.4 million as debt was paid down, and the effective tax rate dropped to 30.0% from 34.0% on a capital loss and an IRS audit settlement.

Note that the 2004 net income includes a roughly $30 million^b additional pension expense, and management guides to about $13 million more in 2005. Balance sheet strength improved materially. Total debt fell to $989 million from $1,391 million, reducing the debt-to-debt-equity ratio to 24.9% from 35.6%, well below the 50% covenant.

Operating cash flow hit a record $662 million^c despite $146 million in discretionary pension and benefit contributions. Backlog rose to $2.20 billion from $1.80 billion, with 82.2% scheduled for delivery within twelve months, which supports the company's outlook for higher sales and operating income in fiscal 2005. Shareholders' equity grew to $2.98 billion, and the company has paid dividends for 216 consecutive quarters, with a current annual rate of $0.76 per share.

Key risks to monitor include rising raw material costs that may not be recoverable through pricing, persistent pension and health care cost pressure, and environmental remediation exposure, with a reserve of $20.4 million^d against an estimated range of $20.4 million to $60.4 million across 28 facilities and several off-site sites. Acquisition activity increased, with $200 million in net cash outflow in 2004, and management says more acquisitions are being pursued, which could affect future capital allocation and integration results.

02—Key points

Key Highlights

Net sales rose 10.9% to $7.107 billion (vs. $6.411 billion in FY2003), led by Industrial segment volume growth, the Denison acquisition, and favorable currency effects.
Net income more than doubled to $345.8 million, or $2.91 diluted EPS, up from $1.68; net margin improved to 4.9% from 3.1%.
Gross profit margin expanded to 19.2% from 17.2%, reflecting higher volume, lean manufacturing, and financial performance initiatives.
Total debt was reduced to $989 million from $1.39 billion, and the debt-to-debt-equity ratio fell to 24.9% from 35.6%, well inside the 50% covenant limit.
Record operating cash flow of $662 million, even after $146 million in discretionary pension and benefit plan contributions.
Backlog increased to $2.20 billion from $1.80 billion, with 82.2% scheduled for delivery within the next twelve months, supporting management's outlook for higher sales and operating income in FY2005.
Dividends have been paid for 216 consecutive quarters and increased for 48 straight years; the current annual rate is $0.76 per share.

03—Questions

Frequently Asked Questions

What drove the large increase in Parker-Hannifin's FY2004 earnings?
Net income rose to $345.8 million from $196.3 million, mainly from higher sales volume in the Industrial segment, better gross margins from manufacturing efficiency and cost initiatives, and lower interest expense. The effective tax rate also fell to 30.0% from 34.0%, due to a capital loss used to offset capital gains and an IRS audit settlement. Some of this benefit is non-recurring in nature, so investors should separate it from run-rate operating performance.
How strong is Parker-Hannifin's balance sheet and liquidity position?
The balance sheet strengthened considerably. Debt fell by about $400 million to $989 million, the debt-to-debt-equity ratio dropped to 24.9%, and the company holds $825 million in committed credit lines with A-1/P-1 commercial paper ratings. Working capital reached $1.28 billion with a current ratio of 2.01. Management reports compliance with all covenants, including the debt-to-total-capitalization limit of less than 50%.
What are the main risks and outlook items disclosed for fiscal 2005?
Management highlighted rising raw material costs that may not be fully recovered through pricing, continued pressure from employee retirement and health care costs, and expected 2005 pension expense about $13 million higher than 2004. Environmental remediation covers 28 facilities and two off-site and three regional sites, with a reserve of $20.4 million against a possible total liability of up to $60.4 million. Management expects sales and operating income to rise in FY2005 on stronger North American industrial demand and commercial aerospace recovery, though additional business realignment charges may be needed.
How much is Parker-Hannifin investing in acquisitions and R&D?
The company spent about $200 million net on acquisitions in FY2004, mainly the $255 million Denison International purchase (completed February 2004), with additional tuck-in deals. Research and development costs were $143.1 million, up from $122.7 million, though $48.4 million of that was reimbursed by customers. Management said it is exploring further acquisitions, which may be funded with borrowings, and capital expenditures are expected to be about 3.5% of sales in FY2005.

04—Continue

← View all 10-K filings